Unknown

Dataset Information

Potential new uses of non-vitamin K antagonist oral anticoagulants to treat and prevent stroke.


ABSTRACT:

Background

Non-vitamin K antagonist oral anticoagulant (NOAC) drugs are at least equivalent to warfarin for ischemic stroke prevention in patients with atrial fibrillation and have a lower risk of intracranial hemorrhage. The role of these agents in the prevention and treatment of other types of cerebrovascular disease remains unclear.

Methods

We reviewed the literature (randomized trials, exploratory comparative studies, and case series) on the use of NOACs in patients with atrial fibrillation, venous thromboembolism, and cerebrovascular disease independent of atrial fibrillation.

Results

The literature on the use of NOACs for treatment and prevention of cerebrovascular disease in patients without atrial fibrillation is sparse. The potential benefit of vitamin K anta

SUBMITTER: Yaghi S 

PROVIDER: S-EPMC4603598 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature